F11R and breast carcinoma: In our recent study, we utilized the F11R/JAM-A peptide antagonist P4D that disturbs the homophilic interactions between F11R/JAM-A molecules located on the surfaces of two different, adjacent cells and thus inhibits the tight junctions formation to demonstrate the role of F11R/JAM-A in breast cancer metastasis [6].